Evidence map›Paper›PMID 41885141›Full record

SynthesisBJOG : an international journal of obstetrics and gynaecology2026

Eclampsia Incidence, Management and Outcomes Across Multi-Country Surveillance Cohorts: Individual Participant Data Meta-Analysis.

Silvia Salvi, Donatella Mandolini, Kitty W M Bloemenkamp, Catherine Deneux-Tharaux, Hilde Marie Engjom, Lachmi R Kodan, Diane Korb, Alexandra Krištúfková, Kari Klungsøyr, Ann Langedock and 9 more

Abstract readMeta-Analysis
In one paragraph

Synthesis in BJOG : an international journal of obstetrics and gynaecology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Silvia SalviNational Centre for Disease Prevention and Health Promotion, Istituto Superiore di Sanità-Italian National Institute of Health, Rome, Italy.ORCID https://orcid.org/0000-0001-7793-9612
Donatella MandoliniNational Centre for Disease Prevention and Health Promotion, Istituto Superiore di Sanità-Italian National Institute of Health, Rome, Italy.
Kitty W M BloemenkampDepartment of Obstetrics, Birth Centre Wilhelmina Children Hospital, Division Women and Baby, University Medical Centre Utrecht, Utrecht, the Netherlands.
Catherine Deneux-TharauxUniversité Paris Cité, CRESS, Obstetrical Perinatal and Pediatric Lifelong Epidemiology Research Team, OPPaLE, INSERM, INRAE, Paris, France.ORCID https://orcid.org/0000-0002-6561-3321
Hilde Marie EngjomDivision of Public Health and Prevention, Department of Health Promotion, Norwegian Institute of Public Health, Bergen, Norway.
Lachmi R KodanDepartment of Obstetrics, Academic Hospital of Paramaribo, Paramaribo, Suriname.
Diane KorbUniversité Paris Cité, CRESS, Obstetrical Perinatal and Pediatric Lifelong Epidemiology Research Team, OPPaLE, INSERM, INRAE, Paris, France.
Alexandra KrištúfkováFirst Department of Obstetrics and Gynaecology of Faculty of Medicine, Comenius University and University Hospital, Bratislava, Slovakia.
Kari KlungsøyrDivision of Public Health and Prevention, Department of Health Promotion, Norwegian Institute of Public Health, Bergen, Norway.
Ann LangedockDepartment of Obstetrics and Gynecology, Groeninge Hospital, Kortrijk, Belgium.
Camilla Tjønneland MentzoniDivision of Public Health and Prevention, Department of Health Promotion, Norwegian Institute of Public Health, Bergen, Norway.ORCID https://orcid.org/0000-0002-1437-2660
Liam McCulloughFirst Department of Obstetrics and Gynaecology of Faculty of Medicine, Comenius University and University Hospital, Bratislava, Slovakia.
Rema RamakrishnanNational Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.ORCID https://orcid.org/0000-0002-6784-8319
T P Timme SchaapDepartment of Obstetrics, Birth Centre Wilhelmina Children Hospital, Division Women and Baby, University Medical Centre Utrecht, Utrecht, the Netherlands.
Aurélien SecoUniversité Paris Cité, CRESS, Obstetrical Perinatal and Pediatric Lifelong Epidemiology Research Team, OPPaLE, INSERM, INRAE, Paris, France.
Griet VandenbergheBelgian Obstetric Surveillance System, Belgium.ORCID https://orcid.org/0000-0002-7420-5020
Kim J C VerschuerenDepartment of Obstetrics, Birth Centre Wilhelmina Children Hospital, Division Women and Baby, University Medical Centre Utrecht, Utrecht, the Netherlands.
Serena DonatiNational Centre for Disease Prevention and Health Promotion, Istituto Superiore di Sanità-Italian National Institute of Health, Rome, Italy.ORCID https://orcid.org/0000-0002-4607-2072
INOSS Group (International Network of Obstetric Survey Systems)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo estimate the incidence of eclampsia, characterise maternal and perinatal profiles, and document outcomes across seven countries within the International Obstetric Survey System and identify inter-country differences that may improve maternal and perinatal care.

designMulti-country analysis of population-based cohort data.

settingSix high-income countries (Belgium, France, Italy, the Netherlands, Norway, Slovakia) and one upper-middle-income country (Suriname). POPULATION: All women admitted with eclampsia in participating countries between 2012 and 2019.

methodsIndividual participant data meta-analysis.

main outcome measuresIncidence of eclampsia, maternal demographics, pregnancy characteristics, clinical management, mode of delivery and maternal and perinatal outcomes.

results615 cases of eclampsia were notified resulting in a pooled incidence of eclampsia of 2.2 per 10,000 deliveries in high-income countries and 36.6 per 10,000 deliveries in Suriname. About 42% of women were diagnosed with preeclampsia before seizure onset and one-third experienced their first seizure postpartum. Hypertension was the most reported clinical sign (91.1%). Most women were treated with magnesium sulphate (91.1%) and antihypertensive medications (89.8%). Caesarean section was performed in 72.7% of cases. About 53% of births was preterm with most of them linked to antepartum cases. Maternal and neonatal deaths were rare but more frequent in Suriname.

conclusionsThe declining incidence of eclampsia in Europe may be attributed to enhanced management, supported by ongoing audits and confidential enquiries; however, potential ascertainment bias limits causal interpretation. Global efforts remain crucial to promote awareness, timely prevention and implement standardised management guidelines for eclampsia across all settings.

Indexed as

EclampsiaAdultAntihypertensive AgentsCesarean SectionCohort StudiesDeveloped CountriesFemaleHumansIncidenceInfant, NewbornPregnancyPregnancy OutcomeAntihypertensive Agentseclampsiamagnesium sulphatematernal healthmaternal mortalityperinatal care

Identifiers

PMID41885141
PMCPMC13254014

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.